
Team
Our management team, board and scientific advisory board have vast experience in the global pharma industry and provide a wealth of expertise.
Executive Leadership
Board of Directors
Strategic Advisory Council
The Nxera Strategic Advisory Council is an advisory body to provide strategic guidance and expert advice to the executive management of Nxera Pharma. The Council is composed of Japanese and international industry leaders, selected for their extensive international commercial, regulatory and government affairs, business development and operational experience in the pharmaceutical industry.

Mr. Yoshiyasu Ninomiya
Mr. Ninomiya has over 30 years of management experience and a solid academic background in science and business with a career spanning both the pharmaceutical industry and corporate investment. He began his career at Astellas Pharma where he played a key role in establishing and driving the growth of its U.S. business, particularly in Marketing and Sales. He then joined AstraZeneca’s Global Headquarters, leading critical international projects for the Executive Vice President, before transferring to AstraZeneca Japan to oversee the entire Primary Care operations. Subsequently, Mr. Ninomiya served as General Manager at Abbott Japan and later joined Novartis Pharma Japan, where he successfully launched several key products as COO and President. He then transitioned to Orix Corporation as Senior Advisor for Business Investment and Development, focusing on the healthcare industry. In addition to his corporate career, he serves as a Professor at The Graduate School of Project Design. Mr. Ninomiya holds a Bachelor's degree in applied science from Waseda University and an MBA from the University of Chicago.